Rosa Executive Impact Workshop #2
Mike Reed, PhD, Chief Scientist and Ron Beaver, PhD, Founder
Executives and decision-makers are invited to attend Rosa’s upcoming exclusive Executive Impact Weekly Workshop event. You will get an opportunity to hear directly from Rosa’s Founder, Ron Beaver, PhD, and Chief Scientist, Mike Reed, PhD, and to explore how Rosa’s PhysioPD Research can be useful for your company.
Please join us as we discuss Rosa's collaboration with Daiichi Sankyo in which we applied a custom PhysioPD Research Platform to evaluate the clinical efficacy of a novel atopic dermatitis treatment compared to dupilumab. PhysioPD Research delivered novel mechanistic insights that identified the specific patient types likely to respond to Daiichi's drug, increasing trial success.
Please note that attendance will be limited to first 5 respondents to ensure opportunity for in-depth discussion.